Clinical trials
Failure to Thrive trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2011 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 1 |
| 2023 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Terminated | 5 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Approved for marketing | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ascendis Pharma Endocrinology Division A/S | 4 |
| Ascendis Pharma A/S | 2 |
| Brigham and Women's Hospital | 2 |
| Arkansas Children's Hospital Research Institute | 1 |
| Baylor College of Medicine | 1 |
| Columbia University | 1 |
| Eli Lilly and Company | 1 |
| Kaiser Permanente | 1 |
| Medical College of Wisconsin | 1 |
| Medical University of South Carolina | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Failure to Thrive | 30 |
| Dwarfism, Pituitary | 5 |
| Endocrine System Diseases | 5 |
| Dwarfism | 4 |
| Premature Birth | 4 |
| Pituitary Diseases | 3 |
| Bronchopulmonary Dysplasia | 2 |
| Growth Disorders | 2 |
| Heart Defects, Congenital | 2 |
| Infant Nutrition Disorders | 2 |
Trials
Showing 26 to 30 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.